SCHEMBL24716298

SCHEMBL24716298

CC(C)S(=O)(=O)c1ccccc1Nc1ccnc(Nc2cc3c(n(C)c2=O)CCN(C)C3)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 16/20 0.52
▸ CDK7 P50613 1/20 0.50
▸ CDK9 P50750 1/20 0.50
▸ MAP4K1 Q92918 3/20 0.48
▸ INSR P06213 2/20 0.43
▸ KCNH2 Q12809 1/20 0.43
▸ MET P08581 1/20 0.42
▸ EGFR P00533 2/20 0.42
▸ EML4 Q9HC35 2/20 0.42
▸ BMPR1B O00238 1/20 0.42
▸ PLK4 O00444 1/20 0.42
▸ GAK O14976 1/20 0.42
▸ ERN1 O75460 1/20 0.42
▸ STK10 O94804 1/20 0.42
▸ ABL1 P00519 1/20 0.42
▸ LCK P06239 1/20 0.42
▸ FYN P06241 1/20 0.42
▸ NPM1 P06748 1/20 0.42
▸ FES P07332 1/20 0.42
▸ YES1 P07947 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29869206 1.00 ALK (0.52) ALKCDK7CDK9MAP4K1INSR
SCHEMBL29869150 0.91 MAP4K1 (0.50) ALKMAP4K1PTK2AURKB
SCHEMBL24716308 0.91 MAP4K1 (0.50) ALKMAP4K1PTK2AURKB
SCHEMBL24716051 0.89 MAP4K1 (0.49) ALKCDK7CDK9MAP4K1AURKB
SCHEMBL24716360 0.84 ALK (0.73) ALKINSRKCNH2MET
SCHEMBL24716300 0.84 MAP4K1 (0.49) ALKMAP4K1EGFR
SCHEMBL24716054 0.80 MAP4K1 (0.49) MAP4K1EGFR
SCHEMBL24716377 0.75 ALK (0.60) ALKCDK7CDK9MAP4K1INSR
SCHEMBL24716309 0.73 ALK (0.58) ALKMAP4K1AURKB
SCHEMBL24716365 0.73 AXL (0.73) ALKMAP4K1INSRIGF1RAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116848103-A High activity HPK1 kinase inhibitors 杭州阿诺生物医药科技有限公司 2023-10-03 — — CN disclosed
WO-2022214008-A1 HIGHLY ACTIVE HPK1 KINASE INHIBITOR 杭州阿诺生物医药科技有限公司 2022-10-13 — — WO disclosed
Send feedback